Stock Events

Enovis 

€41.4
1
+€0+0% Friday 06:04

Statistics

Day High
41.4
Day Low
41.4
52W High
-
52W Low
-
Volume
0
Avg. Volume
-
Mkt Cap
2.28B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

2MayConfirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
0.37
0.51
0.65
0.79
Expected EPS
0.48
Actual EPS
0.5

People Also Follow

This list is based on the watchlists of people on Stock Events who follow C520.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Smith & Nephew
SNN
Mkt Cap11.52B
Smith & Nephew competes directly with Enovis in the orthopedics segment, offering similar products for joint replacement and repair.
Stryker
SYK
Mkt Cap133.08B
Stryker is a major competitor in the medical technology field, particularly in orthopedics, surgical equipment, and neurotechnology, directly competing with Enovis' product lines.
Zimmer Biomet
ZBH
Mkt Cap23.32B
Zimmer Biomet Holdings, Inc. is a direct competitor in the orthopedic device market, offering a wide range of products for joint reconstruction, similar to Enovis.
Medtronic
MDT
Mkt Cap111.63B
Medtronic competes with Enovis in multiple areas, including surgical products and patient monitoring systems, making it a broad competitor.
Johnson & Johnson
JNJ
Mkt Cap353.97B
Johnson & Johnson, through its medical devices segment, competes across several areas with Enovis, including surgical products and orthopedics.
Boston Scientific
BSX
Mkt Cap113.37B
Boston Scientific Corporation offers products in various medical fields that overlap with Enovis' offerings, including surgical and orthopedic devices.
Abbott Laboratories
ABT
Mkt Cap187.15B
Abbott Laboratories competes with Enovis through its range of medical devices, including vascular and neuromodulation devices, overlapping with Enovis' market.
Globus Medical
GMED
Mkt Cap7.33B
Globus Medical, Inc. competes in the spine orthopedic devices market, offering innovative solutions that rival Enovis' spine-focused products.
Integra Lifesciences
IART
Mkt Cap2.43B
Integra LifeSciences Holdings Corporation offers products in orthopedics and tissue technologies, competing with Enovis in the surgical and orthopedic device market.

About

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.
Show more...
CEO
Mr. Matthew L. Trerotola
Employees
6550
Country
US
ISIN
US1940145022
WKN
000A3DHHV

Listings